Inhibition of normal human macrophage progenitors by retinoic acidJANUSZEWICZ, E; COOPER, I. A.British journal of haematology. 1984, Vol 58, Num 1, pp 119-128, issn 0007-1048Article

The variation of traits related to heterostyly of buckweat (Fagopyrum esculentum Moench) flowersSAMBORSKA-CIANA, A; JANUSZEWICZ, E; OJCZYK, T et al.1989, Vol 9, pp 27-30Article

Hypercalcemia complicating myelomonoblastic transformation of chronic myeloid leukemiaATTAR, E; PROKOCIMER, M; JANUSZEWICZ, E et al.Acta haematologica. 1988, Vol 79, Num 4, pp 211-212, issn 0001-5792Article

A therapeutic trial will low-dose cytarabine in myelodysplastic syndromes and acute leukemiaINBAL, A; JANUSZEWICZ, E; RABINOWICTZ, M et al.Acta haematologica. 1985, Vol 73, Num 2, pp 71-74, issn 0001-5792Article

Secondary myelodysplastic syndrome following bone marrow transplantation : report of two casesCHAN, T; JUNEJA, S; WOLF, M et al.Bone marrow transplantation (Basingstoke). 1994, Vol 13, Num 2, pp 145-148, issn 0268-3369Article

Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis : clinical features and course of M-bcr negative and M-bcr positive CMLDOBROVIC, A; MORLEY, A. A; SESHADRI, R et al.Leukemia. 1991, Vol 5, Num 3, pp 187-190, issn 0887-6924, 4 p.Article

Blastic transformation of chronic lymphocytic leukemia = Transformation blastique de la leucémie lymphoïde chroniqueJANUSZEWICZ, E; COOPER, I. A; PILKINGTON, G et al.American journal of hematology. 1983, Vol 15, Num 4, pp 399-402, issn 0361-8609Article

Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignanciesTAM, Constantine S; WOLF, Max M; JANUSZEWICZ, E. Henry et al.Cancer. 2004, Vol 100, Num 10, pp 2181-2189, issn 0008-543X, 9 p.Article

Correlation of cytogenetics, BCR-ABL PCR studies and fluorescence in situ hybridisation (FISH) in adult acute lymphoblastic leukaemiaCAMPBELL, L. J; MARTINOW, A; MICHAEL, P. M et al.Australian and New Zealand journal of medicine. 1999, Vol 29, Num 5, pp 707-712, issn 0004-8291Article

Treatment-related myelodysplasia following fludarabine combination chemotherapyTAM, Constantine S; SEYMOUR, John F; PRINCE, H. Miles et al.Haematologica (Roma). 2006, Vol 91, Num 11, pp 1546-1550, issn 0390-6078, 5 p.Article

BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administrationCAMPBELL, Lynda J; PATSOURIS, Crisoula; RAYEROUX, Kathleen C et al.Cancer genetics and cytogenetics. 2002, Vol 139, Num 1, pp 30-33, issn 0165-4608, 4 p.Article

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-hodgkin lymphomaTAM, Constantine S; WOLF, Max; PRINCE, H. Miles et al.Cancer. 2006, Vol 106, Num 11, pp 2412-2420, issn 0008-543X, 9 p.Article

The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disordersPOLIZZOTTO, Mark N; TAM, Constantine S; MILNER, Alvin et al.Cancer. 2006, Vol 107, Num 4, pp 773-780, issn 0008-543X, 8 p.Article

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapyCARNEY, D. A; WESTERMAN, D. A; SEYMOUR, J. F et al.Leukemia. 2010, Vol 24, Num 12, pp 2056-2062, issn 0887-6924, 7 p.Article

Ifosfamide in combination with paclitaxel or doxorubicin : regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerPRINCE, H. M; GARDYN, J; JANUSZEWICZ, E. H et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 5, pp 427-435, issn 0268-3369Article

Docetaxel effectively mobilizes peripheral blood CD34⁺ cellsPRINCE, H. M; TONER, G. C; WOLF, M et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 5, pp 483-487, issn 0268-3369Article

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer : results of a phase I studyPRINCE, H. M; RISCHIN, D; JUNEJA, S et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 9, pp 955-961, issn 0268-3369Article

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphomaCHEAH, C. Y; HERBERT, K. E; PRINCE, H. M et al.British journal of cancer. 2014, Vol 111, Num 6, pp 1072-1079, issn 0007-0920, 8 p.Article

Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer : Results of a phase I studyPRINCE, H. M; MILLWARD, M. J; JANUSZEWICZ, E. H et al.Annals of oncology. 1999, Vol 10, Num 4, pp 479-481, issn 0923-7534Article